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BACKGROUND: This paper extends the findings of the
Cochrane systematic review of audit and feedback on
professional practice to explore the estimate of effect
over time and examine whether new trials have added
to knowledge regarding how optimize the effectiveness
of audit and feedback.
METHODS: We searched the Cochrane Central Register
of Controlled Trials, MEDLINE, and EMBASE for ran-
domized trials of audit and feedback compared to usual
care, with objectively measured outcomes assessing
compliance with intended professional practice. Two
reviewers independently screened articles and abstract-
ed variables related to the intervention, the context, and
trial methodology. The median absolute risk difference
in compliance with intended professional practice was
determined for each study, and adjusted for baseline
performance. The effect size across studies was
recalculated as studies were added to the cumulative
analysis. Meta-regressions were conducted for studies
published up to 2002, 2006, and 2010 in which
characteristics of the intervention, the recipients, and
trial risk of bias were tested as predictors of effect size.
RESULTS: Of the 140 randomized clinical trials (RCTs)
included in the Cochrane review, 98 comparisons from
62 studies met the criteria for inclusion. The cumula-
tive analysis indicated that the effect size became stable
in 2003 after 51 comparisons from 30 trials. Cumula-
tive meta-regressions suggested new trials are contrib-
uting little further information regarding the impact of
common effect modifiers. Feedback appears most effec-
tive when: delivered by a supervisor or respected
colleague; presented frequently; featuring both specific
goals and action-plans; aiming to decrease the targeted
behavior; baseline performance is lower; and recipients
are non-physicians.
DISCUSSION: There is substantial evidence that audit
and feedback can effectively improve quality of care, but
little evidence of progress in the field. There are
opportunity costs for patients, providers, and health
care systems when investigators test quality improve-
ment interventions that do not build upon, or contrib-
ute toward, extant knowledge.
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BACKGROUND
Audit and feedback is widely used as a strategy to improve
professional practice, either on its own or as a key component
of multifaceted quality improvement (QI) interventions.
Providing data regarding clinical performance may overcome
health professionals’ limited abilities to accurately self-assess
their performance.1 It is posited that when well-designed
feedback demonstrates suboptimal performance for important
and actionable targets, recipients are more likely to respond
with efforts to improve quality of care.2
The most recent Cochrane systematic review and meta-
analysis of audit and feedback included 140 randomized
clinical trials (RCTs),3 making audit and feedback one of
the most studied healthcare quality improvement (QI)
interventions. Three Cochrane reviews over the course of
10 years came to the same conclusion: Audit and feedback
generally leads to small but potentially important im-
provements in professional practice (Table 1).3–5 Yet
despite the increasing number of audit and feedback trials
(Fig. 1), uncertainty remains regarding when audit and
feedback is likely to be most helpful and how to best
optimize the intervention.6
An abstract of the preliminary findings were presented at the Cochrane
Colloquium, October 2011.
Received November 26, 2013
Revised April 7, 2014
Accepted May 16, 2014
Published online June 26, 2014
JGIM
1534
In some instances, audit and feedback is highly effective;
learning from such examples is necessary to optimize the
effectiveness of the intervention across different contexts.
The Cochrane review and associated re-analyses have found
that the effectiveness of audit and feedback depends to
some extent on how the intervention is designed and
delivered, suggesting an opportunity to maximize the
impact of this QI strategy on quality of care.3,7,8 However,
there is evidence that many audit and feedback interven-
tions are developed and tested without an explicit attempt to
consider relevant theories or to build upon extant knowl-
edge.9 Ideally, results of early studies would inform the
design of future interventions, and through this process,
cumulative knowledge would lead to more effective QI.
Given the continuing human and financial capital invested
in audit and feedback interventions in health care, it is
important to examine whether newer trials of audit and
feedback have contributed new knowledge to the field.
The purpose of this paper is to extend the results of the
Cochrane review of audit and feedback to explore the
evolution of evidence supporting this QI intervention over
time. In particular, we examined whether effect estimates,
and the precision around those estimates, changed over
time. To do this, we undertook a cumulative analysis of
trials by year of publication and conducted a series of meta-
regressions to understand how the literature has developed
with respect to determining factors that could explain why
audit and feedback is more or less effective.
METHODS
This is a secondary analysis of data from the previously
published Cochrane systematic review of audit and feedback.
Complete methodological details are available3 and are summa-
rized below. Ethics approval was not required for this study.
Eligibility Criteria
Audit and feedback was defined as a “summary of clinical
performance of health care over a specified period of time.”
This secondary analysis only included RCTs that directly
compared audit and feedback (either alone or as the core,
essential feature of a multifaceted intervention) to usual
care. Furthermore, only RCTs that evaluated effects on
provider practice as a primary outcome were included. For
ease of interpretation of the meta-regression and cumulative
meta-analysis, we further limited studies to those that
reported dichotomous outcomes (i.e., compliance with
intended professional practice).
Information Sources, Search, and Study
Selection
A search strategy sensitive for RCTs involving audit and
feedback was applied in December 2010 to the Cochrane
Central Register of Controlled Trials, MEDLINE,
EMBASE, and CINAHL. As previously described,3 we
Table 1. Findings from Cochrane Systematic Reviews and Meta-Analyses of Audit and Feedback Over Time
Year of review Effect size Conclusion
2003 (search up to
January 2001)
Forty-seven studies with dichotomous outcomes: 7 % (IQR:
2–11) median absolute increase in compliance with
intended professional behaviors or processes
“Audit and feedback can be effective in improving
professional practice. When it is effective, the effects are
generally small to moderate. The absolute effects of audit
and feedback are more likely to be larger when baseline
adherence to recommended practice is low.”4
2006 (search up to
January 2004)
Forty-nine studies with dichotomous outcomes: 5 % (IQR:
3–11) median absolute increase in compliance with
intended professional behaviors or processes
“Audit and feedback can be effective in improving
professional practice. The effects are generally small to
moderate. The absolute effects are likely to be larger when
baseline adherence to recommended practice is low and
intensity of audit and feedback is high.”5
2012 (search up to
December 2010)
Sixty-two studies with dichotomous outcomes: 4 % (IQR:
1–16) weighted median absolute increase in compliance
with intended professional behaviors or processes
“Audit and feedback generally leads to small but potentially
important improvements in professional practice. The
effectiveness of audit and feedback seems to depend on
baseline performance and how the feedback is provided.
Future studies of audit and feedback should directly
compare different ways of providing feedback.”3
IQR interquartile range
Figure 1. Cumulative number of randomized trials featuring audit
and feedback as a core component of a quality improvement
intervention.
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developed a MEDLINE search strategy that identified 89 %
of all MEDLINE indexed studies from the previous version
of the review and then translated this strategy into the other
databases using the appropriate controlled vocabulary as
applicable. Search terms included: audit, benchmarking,
feedback, utilization review, health care quality, etcetera,
plus typical search terms to focus on RCTs. Two reviewers
independently screened the titles, abstracts, and full texts to
apply inclusion criteria.
Data Collection Process
Two reviewers independently abstracted data from included
studies. Studies included in the previous version of the
Cochrane review of audit and feedback were reassessed due
to changes in the data abstraction form and methods.
Discrepancies were resolved through discussion. For studies
lacking extractable data or without baseline information, we
contacted investigators via email. Risk of bias for the
primary outcome(s) in each study was assessed according to
the Cochrane Effective Practice and Organization of Care
group criteria10 (sequence generation, allocation conceal-
ment, blinding, incomplete outcome data, selective
reporting, baseline similarity, lack of contamination, and
other). We assigned an overall assessment of the risk of bias
for each study as high, moderate, or low, following the
recommendations in the Cochrane Handbook.11 Studies
with a high risk of bias in at least one domain that decreased
the certainty of the effect size of the primary outcome were
considered to have a high risk of bias. Conversely, when a
study had low risk of bias for each domain, it was deemed
low risk of bias overall. Other studies were considered to
have unclear risk of bias.
Measure of Treatment Effect
We only extracted results for the primary outcome. When the
primary outcome was not specified, we used the variable
described in the sample size calculation as the primary
outcome. When the primary outcome was still unclear or when
the manuscript described several primary process outcomes, we
calculated the median value. We calculated the treatment effect
as an adjusted risk difference (RD) by subtracting baseline
differences from post-intervention differences. Thus, an adjust-
ed RD of +10 % indicates that after accounting for baseline
differences, health professionals receiving the intervention
adhered to the desired practice 10 % more often than those
not receiving the intervention.
Analysis
Across multiple studies, we weighted the median effect by the
number of health care providers. The ‘median of medians’
technique has been used in many similar reviews evaluating
the effect of QI interventions on health professional perfor-
mance,12 due to frequency of unit of analysis errors in the
literature and the great variety of clinical contexts covered in
the studies. For the cumulative analysis, the median adjusted
RD and interquartile range (IQR) was recalculated at each time
point as studies were added. The meta-regression examined
how the adjusted RD was related to explanatory variables,
weighted according to study size (number of health care
professionals). Unlike the meta-regression from the Cochrane
review of audit and feedback,3 high risk of bias studies were
included. The meta-regression also tested the following
potential sources of heterogeneity to explain variation in the
results of the included studies: format (verbal, written, both,
unclear); source (supervisor or senior colleague, professional
standards review organization or representative of employer/
purchaser, investigators, unclear); frequency (weekly, month-
ly, less than monthly, one-time); instruction for improvement
(explicit measurable target or specific goal but no action plan,
action plan with suggestions or advice given to help
participants improve but no goal/target, both, neither);
direction of change required (increase current behavior,
decrease current behavior, mix or unclear); recipient (physi-
cian, other health professional); and study risk of bias (high,
unclear, low). Meta-regression was conducted for all pub-
lished trials as of 2010, 2006 and 2002. Finally, we added year
of publication as a continuous variable to the meta-regression
of all studies as an additional approach to assess whether this
variable accounted for a significant portion of the heterogene-
ity. We conducted a multivariable linear regression using main
effects only. Baseline compliance and year of publication were
treated as continuous explanatory variables and the others as
categorical. The analyses were conducted using the
GLIMMIX procedure in SAS Version 9.2 (SAS Institute Inc.
Cary, NC USA), accounting for the dependency between
comparisons from the same trial.
RESULTS
Of the 140 RCTs included in the Cochrane review, 98
comparisons from 62 studies met the criteria for this study
(Fig. 2). These studies included over 2,300 groups of
healthcare providers (e.g., clinics or hospitals) from 38 trials
allocating clusters of professionals, and more than 2,000
professionals from 24 trials allocating individual healthcare
providers. Characteristics of these studies are described in
Table 2. Most studies took place in the USA or Canada
(55 %), and outpatient care was the most common
setting (69 %). The feedback was delivered by either the
investigators or by an unclear source in 85 % of studies.
In 47 % of the studies, the feedback was only delivered
once, and in 61 % the feedback did not include an
explicit goal or action plan.
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The cumulative analysis revealed little change in the
median effect or the interquartile range over the course of
25 years (Fig. 3). The median improvement in adherence to
intended practice in 2002 after 51 comparisons had been
published was 5.7 (IQR=1.65–10.85), the effect in 2006
after 86 comparisons was 3.5 (IQR=0.65–9.00), and the
effect after including all 98 comparisons was 4.4 (IQR=
1.04–10.90).
The meta-regression revealed that heterogeneity in effect
sizes could be explained in part by feedback characteristics,
but year of publication did not explain a significant portion
of the variability in effect size (Table 3). Feedback seemed
most effective when it was: delivered from a supervisor or
respected colleague; presented more than once; featuring
both specific goals and action-plans; aiming to decrease the
targeted behavior; with lower baseline performance; and
when recipients were non-physicians. Studies published
after 2006 did not change the meta-regression results
statistically; differences in the estimated effect for most
feedback characteristics have been apparent qualitatively
since 2002. For example, although the p value was not
significant for source of feedback in 2002, the estimated
adjusted risk difference for feedback delivered by a
supervisor or respected colleague (24.5) was higher than
feedback delivered by study investigators (17.9) or feed-
back from a representative of a regulatory agency or
employer (0.9).
DISCUSSION
Audit and feedback works; the median effect is small
though still potentially important at the population level,
and 27/98 comparisons (28 %) resulted in an improve-
ment of at least 10 % in quality of care.3 Small
differences in the results seen in these re-analyses
compared to the results of the Cochrane review are
due to the lack of weighting in the cumulative analysis
and the inclusion of high risk of bias studies in the
meta-regression. Nevertheless, the expected effect of an
intervention comparing audit and feedback to usual care
has changed very little over the last two decades.
Furthermore, new trials have provided little new knowl-
edge regarding key effect modifiers. Given the lack of
equipoise, it may no longer be ethically appropriate to
continue to direct human and financial resources toward
trials comparing audit and feedback against usual care,
especially for common conditions in common settings.
At this point, the appropriate question is not, ‘can audit
and feedback improve professional practice?’ but ‘how
Figure 2. Study flow diagram.
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can the effect of audit and feedback interventions be
optimized?’
Based on our analyses, feedback seems most effective
when it: is delivered by a supervisor or respected colleague;
is presented frequently; includes both specific goals and
action-plans; aims to decrease the targeted behavior;
focuses on a problem where there was larger scope for
improvement; and when the recipients are non-physicians.
Unfortunately, relatively few trials feature these compo-
nents. Furthermore, our findings suggest that investigators
are not building upon best practices. For example, despite
evidence that repeated feedback is more effective, studies
that evaluate interventions after only one cycle of feedback
continue to be performed. Furthermore, of the 32 studies
conducted after 2002 considered in this analysis, feedback
was delivered by a supervisor or respected colleague only
six times, and no studies included feedback with both
explicit goals and action plans. As a result, even after 140
randomized trials of audit and feedback, it remains difficult
to identify how to optimize audit and feedback.6 For
instance, although a ‘supervisor or respected colleague’
appears to be the most effective source to deliver feedback,
precise strategies to reliably identify and leverage such
sources are not well known.13 In addition, while it is
advisable for action plans to accompany feedback since the
downside is minimal, the best way to operationalize this is
unknown.7,14 It is noteworthy that explicit targets without
action plans do not seem to be particularly helpful. To
achieve performance targets, recipients of feedback benefit
from correct solution information8 that can focus their
attention on the targeted behavior(s).
Cumulative meta-analyses have previously been used to
investigate whether future trials would be likely to change
the conclusions regarding the effectiveness of QI or health
services interventions.15,16 For audit and feedback, it is
plausible that further studies comparing the intervention
against control may be informative if they are conducted for
settings, professional groups or behaviors not well targeted in
the current review (although relatively few additional trials
should be needed to confirm whether observed effects are
broadly aligned with observed effects across the body of
literature). We recognize the risks of cumulative meta-analysis
with respect to multiple testing and escalating type one error.17
However, since the Cochrane review did not include a
variance around the intervention effect, the figures showing
the results of our cumulative analysis do not feature error bars
as in the seminal examples of Lau et al.18 Additionally, the
number of characteristics tested in the meta-regression was
limited by statistical and pragmatic concerns. Variables were
only chosen for abstraction if there was an a priori directional
Table 2. Characteristics of Studies
Study characteristic No. % Intervention characteristic No. %
Publication year Format
2007–2009 10 16.1 Verbal 6 9.7
2003–2006 22 35.5 Written 34 54.8
1996–2002 20 32.4 Both 18 29.0
1986–1995 5 8.1 Unclear 4 6.5
Before 1986 5 8.1 Source
Country Supervisor/colleague 6 9.7
USA 27 43.6 Employer 3 4.8
UK or Ireland 7 11.3 Investigators/unclear 53 85.5
Canada 7 11.3 Frequency
Australia or New Zealand 6 9.7 Monthly or more 11 17.7
Other 15 24.2 Repeated less than monthly 19 30.7
Unit of allocation Once only 29 46.8
Provider 24 38.7 Instructions for improvement
Many providers/groups 38 61.3 Goal-setting 5 8.1
Unit of analysis Action planning 16 25.8
Patient 37 59.7 Both 3 4.8
Provider 12 19.4 Neither 38 61.3
Many providers/groups 12 19.4 Nature of change required
Unclear 1 1.6 Increase current behavior 29 46.8
Risk of bias Decrease current behavior 6 9.7
Low 21 33.9 Mix or unclear 27 43.6
Unclear 29 46.8 Clinical topic
High 12 19.4 Diabetes 11 17.7
Number of arms in trial Laboratory testing/radiology 3 4.8
Two 41 66.1 Prescribing 18 29.0
Three 10 16.1 Other 30 48.4
Four 11 17.7 Targeted health professional
Clinical setting Physicians 51 82.3
Outpatient 43 69.4 Other 11 17.7
Inpatient 14 22.6 Medical specialty (could be>1)
Other/unclear 5 8.1 GP/family physician 39 62.9
Internists 25 40.3
Other 20 32.3
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hypothesis and a belief that data would be available in
published reports. Confidence in the results of the meta-
regression is limited by reliance upon indirect comparisons
and risk of ecological fallacy. In other words, relationships
identified across studies through meta-regression may not
reflect relationships evident within studies; this is also known
as aggregation bias. Finally, as with any review, the limitations
of the primary studies must be considered.
We acknowledge that many other potential variables,
including the clinical topic and context, likely impact the
effectiveness of the intervention.19,20 Amongst the 98
comparisons, there were 41 comparisons testing audit and
feedback alone and 57 comparisons testing audit and
feedback as the core, essential part of a multifaceted
intervention. It is plausible that co-interventions may
interact with the effect modifiers tested in the meta-
regressions. A recent international meeting was conducted
to identify high-yield research questions for understanding
how to enhance the effectiveness of audit and feedback.
Stakeholders suggested a need for more research to better
understand how contextual and recipient characteristics
moderate audit and feedback effectiveness, characteristics
of the desired behavior change that make a good target for
audit and feedback, and how the specific design of the audit
and feedback intervention interacts with these factors.21
Given the importance of audit and feedback as a key
component of many QI interventions, there is a need to
identify opportunities to sequentially and systematically test
various approaches to the design and development of audit
and feedback. Researchers can continue to conduct unco-
ordinated trials of audit and feedback versus usual care and
rely upon periodically conducted meta-regressions across
studies to explore effect modifiers. But the results will be at
risk of ecological fallacies, and as demonstrated here, this
approach has resulted in minimal advances over time.
Alternatively, researchers could achieve greater confidence
in causal inference regarding more effective intervention
design through a limited number of multi-arm trials with
direct, head-to-head comparisons testing different ap-
proaches for designing and delivering audit and feedback.
Another approach that could help advance cumulative
knowledge regarding audit and feedback and other QI
Figure 3. Cumulative analysis–effect size* of audit and feedback interventions over time (AF: audit and feedback; *absolute difference in
compliance with intended professional behaviors).
1539Ivers et al.: Audit and Feedback in Health CareJGIM
strategies would be to consider engineering-based method-
ological options that enable testing of multiple potential
effect modifiers, such as theory-driven factorial and/or
sequential adaptive trials.22 Future audit and feedback
interventions should feature the aspects known to be
associated with greater effectiveness and future trials should
be powered to find relatively small effect sizes, especially in
the case of head-to-head trials. This proposed shift in
direction for QI trials parallels the movement to limit
placebo-controlled trials of clinical interventions and to
increase focus on comparative effectiveness research.23
The findings of this review suggest that QI trialists
have failed to cumulatively learn from previous studies
(or from systematic reviews). Rather, it would appear
that the norm for those testing audit and feedback
interventions is to ‘re-invent the wheel’, repeating rather
than learning from and contributing to extant knowl-
edge.24 As highlighted in the recent series on increasing
value and reducing waste in research,25 the opportunity
cost of continuing in the current manner is large for
patients, providers, and health systems. A coordinated
approach toward building upon previous literature and
relevant theory to identify the key, active ingredients of
interventions would help QI stakeholders achieve greater
impact with their interventions and produce outcomes
that are more generalizable.26,27 In particular, QI trialists
could benefit from adapting the model of the Children’s
Oncology Group, which has successfully shared re-
sources to accelerate progress.28 At a minimum, for
stakeholders involved in the funding and conduct of QI
trials, this analysis emphasizes the need for trials of
carefully planned interventions with explicitly justified
components to ensure that the field of QI in healthcare
can move forward.
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Table 3. Factors Explaining Variability in Effectiveness of Feedback: Serial Meta-Regressions
Characteristic of feedback Estimated effect size*, (no. studies)
2010 2006 2002
Format of feedback p=0.386 p=0.731 p=0.729
Verbal 12.77, (15) 14.85, (14) 17.02, (12)
Written 20.70, (50) 19.94, (41) 23.76, (19)
Both verbal and written 19.05, (27) 19.19, (26) 16.98, (18)
Not clear 16.90, (6) 13.58, (5) 2.94, (2)
Source of feedback p=0.006 p=0.034 p=0.300
A supervisor or respected colleague 25.22, (10) 23.49, (8) 24.48, (4)
Standards review org. or representative of employer 9.16, (3) 9.38, (3) 0.90, (1)
The investigators 15.19, (52) 14.71, (42) 17.85, (13)
Not clear 19.85, (33) 19.99, (33) 17.47, (33)
Frequency of feedback p<0.001 p<0.001 p<0.001
Frequent (up to weekly) 27.58, (5) 28.50, (3) 28.64, (2)
Moderate (up to monthly) 18.51, (10) 16.73, (9) 18.31, (4)
Infrequent (less than monthly) 14.04, (26) 13.32, (22) 1.06, (10)
Once only 7.49, (52) 7.75, (47) 9.96, (30)
Unclear; 19.15, (5) 18.17, (5) 17.92, (5)
Instructions for improvement p=0.044 p=0.068 p=0.325
Explicit, measurable target, but no action plan 10.88, (5) 10.45, (5) 8.48, (1)
Action plan, but no explicit target 17.16, (32) 16.69, (31) 11.37, (18)
Both 23.19, (4) 23.06, (4) 22.01, (4)
Neither; 18.18, (57) 17.37, (46) 18.84, (28)
Nature of change required p=0.025 p=0.028 p=0.510
Increase current behavior 15.55, (40) 15.65, (36) 19.34, (17)
Decrease current behavior 22.46, (11) 22.30, (11) 12.61, (4)
Change behavior to similar alternative or unclear 14.05, (47) 12.73, (39) 13.58, (30)
Profession of recipient (Physician yes/no) p<0.001 p<0.001 p<0.001
Physician 10.99, (82) 10.19, (72) 4.80, (45)
Not physician 23.72, (16) 23.60, (14) 25.55, (6)
Risk of bias p=0.375 p=0.564 p=0.281
Yes (low risk of bias) 14.85, (32) 14.92, (27) 21.34, (8)
Unclear 15.79, (51) 15.33, (48) 10.06, (34)
No (high risk of bias); 21.42, (15) 20.43, (11) 14.12, (9)
Baseline performance (continuous variable) p<0.001 p=0.003 p=0.021
*Absolute difference in compliance with intended professional behaviors
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